Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $7.36 USD
Change Today -0.08 / -1.08%
Volume 2.3M
OREX On Other Exchanges
Symbol
Exchange
NASDAQ GS
Stuttgart
As of 8:10 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Mark D. Booth

Former Chief Commercial Officer, Orexigen Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 19 board members in 2 different organizations across 4 different industries.

See Board Relationships
54--
As of Fiscal Year 2014

Background*

Mr. Mark D. Booth served as the Chief Commercial Officer of Orexigen Therapeutics, Inc. since August 2009 until March 2015. Mr. Booth served as President of Takeda Pharmaceuticals North America Inc. (TPNA) since August 2002 and also served as its Executive Vice President. He has over 25 years of commercial and business development experience. He held senior leadership positions in sales, operations and product development. Prior to joining TPNA, Mr. Booth served as General ...

Read Full Background

Corporate Headquarters*

3344 North Torrey Pines Court
La Jolla, California 92037

United States

Phone: 858-875-8600
Fax: 858-875-8650

Board Members Memberships*

Director

Education*

BS
Northern Illinois University
MBA
J.L. Kellogg School of Management, Northwestern University

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

There is no Stock Options data available.

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
OREX:US $7.36 USD -0.08

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Marc N. Casper Chief Executive Officer, President, Director, Member of Strategy & Finance Committee and Member of Science & Technology Committee
Thermo Fisher Scientific, Inc.
$1.3M
Thomas P. Joyce Jr.Chief Executive Officer, President, Director and Member of Finance Committee
Danaher Corp.
$847.6K
Erez Vigodman Chief Executive Officer, President, Director and Member of Finance & Invesment Committee
Teva Pharmaceutical Industries Limited
--
Pascal Soriot Chief Executive Officer, Executive Director and Member of Disclosure Committee
AstraZeneca PLC
3.1M GBP
Richard A. Gonzalez Chairman, Chief Executive Officer and Chairman of Executive Committee
AbbVie Inc.
$1.6M
Compensation as of Fiscal Year 2014.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact OREXIGEN THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.